(Hypertension. 2001;37:391.)
© 2001 American Heart Association, Inc.
Scientific Contributions |
From the Department of Medicine and Therapeutics (C.D.N., M.W.M., D.G., F.J.C., J.S.C., N.H.A., A.F.), University of Glasgow, Western Infirmary, and Wellcome Surgical Institute University of Glasgow (H.V.O.C.; I.M.M.), Glasgow, United Kingdom; and Endocrinology, Metabolism and Medicine, Northwestern University Medical School (B.J.), Chicago, Ill.
Correspondence to Prof Anna F. Dominiczak, Department of Medicine and Therapeutics, Western Infirmary, Glasgow G11 6NT. E-mail anna.dominiczak{at}clinmed.gla.ac.uk
| Abstract |
|---|
|
|
|---|
Key Words: hypertension stroke genetics SHRSP consomics focal cerebral ischemia middle cerebral artery occlusion
| Introduction |
|---|
|
|
|---|
Ely and Turner4 found that the blood pressure of F2 offspring depended on the strain of the male progenitor in a WKY x SHR cross. Male offspring with an SHR male progenitor had significantly higher pressures than male offspring with a WKY progenitor. The blood pressure of F2 males was compatible with a Y-linked effect on blood pressure. Reciprocal Y-consomic strains (SHR Y chromosome on WKY background and WKY Y chromosome on SHR background) were constructed and confirmed the Y chromosome effect on blood pressure.5 Previous data from our laboratory described 143 F2 rats obtained by crossing SHRSP and WKY, which were phenotyped using a radiotelemetry system. In this study, male F2 hybrids with an SHRSP grandfather had significantly higher blood pressures compared with male F2 hybrids with the WKY grandfather, suggesting that the Y chromosome effect was also present in the SHRSP.6
The SHRSP strain exhibits an increased frequency of spontaneous strokes and an increased volume of infarction after experimentally induced focal cerebral ischemia compared with the WKY reference strain.2 3 To investigate the role of the SHRSP Y chromosome in stroke, we used permanent middle cerebral artery occlusion (MCAO) in an F1 reciprocal cross.7 8 We found that F1 males with an SHRSP male progenitor had smaller infarct than those with a WKY male progenitor. To examine this further, we divided male F2 rats from our previous study according to the origin of their Y chromosome.3 The results were in parallel with those achieved in the F1 study for which F2 males with an SHRSP grandfather had significantly smaller infarcts than those with a WKY grandfather. The aim of the present study was to assess the effect of the SHRSP and WKY Y chromosomes on blood pressure and experimentally induced focal cerebral ischemia by constructing reciprocal consomic strains using a marker-assisted strategy.
| Methods |
|---|
|
|
|---|
Consomic Crosses
The development of the consomic strains used in this
study involved the transfer of the Y chromosome from
WKYGla to the genetic background of
SHRSPGla, and in the reciprocal direction, from
SHRSPGla to the genetic background of
WKYGla. This required the production of
an F1 generation by crossing WKYGla and
SHRSPGla. Male F1 hybrids were then mated to the
desired recipient strain (WKYGla or
SHRSPGla). Ninety-five microsatellite markers
were genotyped in the offspring from this first backcross, 83
of them were used before and were listed
previously.9 Polymorphic
markers D2Wox5, D2Mit3, D2Wox3, D2Wox13,
D2Mit5, D2Mit6, D2Wox15, D2Wox9, D2Wox19, D2Mit21, D2Mit14,
D2Mgh12 were additionally genotyped in the current
study. Selection of these markers was based on the need for a thorough
coverage of the entire rat genome and location around the blood
pressure and stroke QTLs previously identified by
ourselves.3 10
Databases used to fulfil this selection included Ratmap: The Rat Genome
Database, Goteborg University, Sweden at http://ratmap.gen.gu.se/; The
Whitehead Institute Center for Genome Research Rat Mapping Project,
Boston, USA at http://www.genome.wi.mit.edu/rat/public/, and The
Wellcome Trust Center for Human Genetics Genetic Linkage Maps of the
Rat Genome, Oxford, UK at http://www.well.ox.ac.uk/~bihoreau. Males
homozygous for the recipient alleles throughout the remaining
genome were selected as the "best" for breeding and, thus,
backcrossed again to the recipient strain to produce a second backcross
generation. This procedure was repeated in all offspring after every
backcross until the donors genetic background was eradicated as
indicated by the 95 background markers.
Genotyping
To obtain DNA samples from the consomic backcrosses,
the offspring were briefly anesthetized at 4 weeks of age with
halothane and a 4-mm tip from their tail removed into a 1.5-mL
microfuge tube. The wound was immediately sealed with an electric
cauterizer (Engel-Loter 100S), and the tails were stored at -20°C.
Genomic DNA was isolated as previously
described.11 Genotyping was
performed by PCR amplification of DNA around the polymorphic
microsatellite markers from the total genomic DNA using the appropriate
PCR primer pairs custom made by either Research Genetics or Genosys
Biotechnologies as previously
described.3 9 10
Middle Cerebral Artery Occlusion
Anesthesia was induced (5%) and
maintained (1% to 2%) by halothane in oxygen-nitrous oxide (30:70). A
distal segment of the left MCA was occluded by electrocoagulation in
male SHRSP, WKY, and consomic strains using the technique of Tamura et
al12 with monitoring of
physiological variables throughout MCAO and at
24 hours after MCAO as previously
described.3 A temperature
probe inserted into the temporalis muscle was used to reflect the brain
temperature, which was maintained at 37°C throughout the MCAO
procedure. Twenty-four hours after MCAO, tissue was processed for
hematoxylin-eosin staining as previously
described3 for the estimation
of infarct volume by image analysis. Briefly, infarct volume
for each brain was derived from integration of areas of damage over 8
coronal levels with end points for integration 12.5 mm anterior
and 0.05 mm posterior to the interaural
line.13 Infarct volumes were
expressed as a percentage of the volume of the ipsilateral hemisphere
to account for brain swelling and differences in brain size between
strains.
Blood Pressure Measurement
The Dataquest IV telemetry system (Data Sciences
International) was used for the direct measurement of systolic
and diastolic (DBP) arterial pressure as
previously
described.6 9 10
Surgical implantation of each telemetry transmitter took place under
standard sterile conditions at 12 weeks of age. Hemodynamic data were
sampled every 5 minutes for 10 seconds. To allow for a full
stabilization of blood pressure postoperatively, experimental
observations were collected from day 7 to day 42 after surgery as
"baseline hemodynamic measurements." On day 43,
rats on telemetry received 1% sodium chloride (NaCl) in their drinking
water, and this treatment was continued for 2 weeks until they were
killed. Data collected during this period were considered
"salt-loaded hemodynamic
measurements."
Evaluation of Cardiac
Hypertrophy
Immediately after exsanguination, the thorax was
opened and the heart was removed, blotted with tissue paper, and
weighed. The atria and right ventricle were then removed, and the left
ventricle and septum were weighed. Heart weight to body weight (HW:BW,
mg/g) and left ventricle plus septum weight to body weight [(LV+S):BW,
mg/g] ratios were then determined.
Statistical Analysis
A total of 10 080 measurements of each blood pressure
phenotype were made on each animal during the 5-week baseline
phase and 6048 measurements during the 3-week salt-loaded phase. Within
each phase, hemodynamic measurements were separated
into daytime (7 AM to 7
PM) and nighttime (7
PM to 7
AM) periods. Summary
statistics were provided for each combination of experimental phase and
time of day by calculating overall means and standard errors separately
by consomic strain. Comparisons of consomic strains to their
corresponding background parental strains were made by repeated
measures analysis of variance of daytime or nighttime means for
each individual week of the two phases, reporting the F-statistics and
probability value corresponding to the main effects for
strain.
We additionally applied the seasonal and trend decomposition procedure based on Loess (STL),14 because of the large number of measurements obtained by radiotelemetry and the need to correct for autocorrelation between successive time points from the same animal. The STL analysis expresses each hemodynamic series as a sum of components representing overall trend, cyclic behavior, and residual variability, as described previously.14 This analysis was performed to identify differential effects on trends and cyclic variation, over and above simple shifts in mean value, due to the Y chromosome in the consomic strains. Comparisons of cardiac to body weight ratios and infarct volumes were made by unpaired t test and corresponding confidence intervals, and means and standard errors were used as summary statistics.
| Results |
|---|
|
|
|---|
Infarct Volume
Infarct volume in SHRSP males (33.6%±7.6, n=6) was
greater than in WKY males (22.2%±8.0, n=7)
(Figure 1). Infarct volumes in
SP.WKYGlaYw males were not different from those
observed in SHRSP males
(Figure 1). Similarly, infarct volumes in the reciprocal
WKY.SPGlaYs consomic strain males did not differ
from those observed in the parental WKY males
(Figure 1).
|
Blood Pressure
Baseline and salt-loaded systolic blood
pressure (SBP) recorded by radiotelemetry in the consomic strains
are shown in
Figure 2, and daytime and nighttime SBP and DBP means for
both phases are given in
Table 1. The SP.WKYGlaYw consomic
strain showed a significant reduction in SBP of approximately 30 mm Hg
during the salt-loaded period compared with SHRSP parental strain
(F=5.9, P=0.038). However, no
differences in SBP were found during the baseline period between these
strains. In the reciprocal consomic strain,
WKY.SPGlaYs we observed a significant increase
in SBP by approximately 15 mm Hg during the baseline period
compared with the parental WKY strain (F=6.1,
P=0.035). There was also a
tendency for increased SBP in the consomic strain
WKY.SPGlaYs during the salt-loaded phase, but
this difference did not achieve statistical significance.
|
|
The smoothed trend components for SBP for the consomic and parental strains are displayed in Figure 3. For the SP.WKYGlaYw consomic strain we observed a very significant trend divergence (F=9.1, P=0.001) during the salt-loaded phase compared with the SHRSP parental strain. However, no divergence between the strains was found during the baseline period (Figure 3). In the reciprocal consomic strain, WKY.SPGlaYs, there was no divergence during both recording periods compared with the parental strain (Figure 3). Figure 4 displays estimates of the average periodic (or cyclic behavior) over the recording period of SBP for the consomic and parental strains. The average magnitude of the effect of 24-hour periodicity was between -8 and +9 mm Hg, and -5 and +5 mm Hg for consomic SP.WKYGlaYw and WKY.SPGlaYs strains, respectively. The SP.WKYGlaYw consomic strain (Figure 4) showed a very significant reduction in the amplitude of variability throughout the 24-hour period during the salt-loaded period (F=2.96, P<1x10-10), compared with the SHRSP parental strain, although the two strains were similar during the baseline period (F=0.46, P=1.0). Conversely, the WKY.SPGlaYs strain showed a very significant increase in the amplitude of variability (baseline, F=1.24, P=8.8x10-9; salt, F=1.24, P=4.9x10-6) compared with the WKY parental strain (Figure 4).
|
|
Cardiac Hypertrophy
HW:BW ratios in the two consomic strains were not
different from their respective parental strain
(Table 1). Similarly, LV+S:BW ratios were not different
between the consomic and the parental strains
(Table 1).
| Discussion |
|---|
|
|
|---|
Results from our F1 and F2 studies3 7 suggested that the Y chromosome from the SHRSP decreased the sensitivity to cerebral ischemia compared with the WKY Y chromosome. In an F2 study, many other autosomal loci may be cosegregating in the cohort and contributing to the phenotypic difference observed. Therefore, epistatic and ecogenetic interactions between the Y chromosome and autosomal loci might govern its effect on the stroke phenotype in the F2 cohort. Consomic strains presented in this study give a unique opportunity to evaluate the individual role of the Y chromosome in stroke. Our findings are consistent with no contribution of this chromosome to the vulnerability to cerebral ischemia.
Consistent with the results from our F2 cohort,6 the current study demonstrates a Y chromosome effect on blood pressure. In the Y consomic strains produced by Ely and coworkers using the SHR/hsd and WKY/hsd, the addition (or deletion) of the SHR Y chromosome adds (or subtracts) 15 to 20 mm Hg from the parental strain SBP recorded by tail cuff.5 15 In the current study, we used radiotelemetry during the 9-week period and, therefore, the blood pressure data are more comprehensive. The difference in SBP observed during the baseline period in the WKY.SPGlaYs strain is not observed in the SP.WKYGlaYw strain until salt is administered in the drinking water. However, in the Loess analysis only the SP.WKYGlaYw strain produced a significant trend divergence compared with the parental SHRSP strain. The fact that SHRSP is the hypertensive strain and in consequence represents the permissive background might account for this finding.16
Another interesting finding was that observed in the cyclic behavior over the recording period of SBP in the consomic strains. The absence of the SHRSP Y chromosome in the SP.WKYGlaYw strain reduced the amplitude of variability, whereas the presence of the SHRSP Y chromosome increased the amplitude of variability in the WKY.SPGlaYs strain. These differences were magnified when 1% NaCl was added to the rats drinking water. Previous studies demonstrated that high dietary salt exposure significantly increased blood pressure in the SHR and SHRSP strains with less apparent effects in the WKY strain.6 17 18 19
Calhoun et al17 suggested that the sustained salt-induced increase in blood pressure might be related to differences in volume handling and/or differences in sympathetic nervous system activation between the different strains. The latter hypothesis has been confirmed in Y consomic strains using the SHR/hsd and WKY/hsd strains for which the Y SHR chromosome is associated with increased adrenal gland norepinephrine (NE) and chromogranin A content, increased heart and renal NE turnover, increased plasma NE response to acute stress, and reduction in blood pressure after chemical sympathectomy or clonidine treatment.15 20
Very few genetic loci have been identified on the Y chromosome, and no appropriate microsatellite markers have been developed because the Y chromosome is not involved in recombination during meiosis apart from the small pseudoautosomal region. Some of the Y chromosome potential candidate loci are as follows: Sry, testis determining locus; Zfy, zinc finger protein; Sts, steroid sulfatase locus; and Tty, or testosterone timing locus. Ely et al21 proposed that the SHR Y chromosome causes an acceleration of testosterone release and earlier puberty, with a resulting cascade of molecular and neuroendocrine events that contribute to hypertension.
In conclusion, the SHRSP Y chromosome harbours a locus or loci that contribute to SBP. However, we found no contribution to the vulnerability to cerebral ischemia on the Y chromosome.
| Acknowledgments |
|---|
Received October 25, 2000; first decision December 9, 2000; accepted December 18, 2000.
| References |
|---|
|
|
|---|
2. Rubattu S, Volpe M, Kreutz R, Ganten U, Ganten D, Lindpaintner K. Chromosomal mapping of quantitative trait loci contributing to stroke in a rat model of complex human disease. Nat Genet. 1996;13:429434.[Medline] [Order article via Infotrieve]
3. Jeffs B, Clark JS, Anderson N, Gratton J, Brosnan MJ, Gauguier D, Reid JL, Macrae IM, Dominiczak A. Sensitivity to cerebral ischemic insult in a rat model of stroke is determined by a single genetic locus. Nat Genet. 1997;16:364367.[Medline] [Order article via Infotrieve]
4.
Ely DL, Turner MT.
Hypertension in the spontaneously hypertensive rat is linked to the Y
chromosome. Hypertension. 1990;16:277281.
5.
Ely DL, Daneshvar H,
Turner MT, Johnson ML, Salisbury RL. The hypertensive Y chromosome
elevates blood pressure in F11 normotensive
rats. Hypertension. 1993;21:10711075.
6.
Davidson AO, Schork
NJ, Jaques BC, Kelman AW, Sutcliffe RG, Reid JL, Dominiczak A. Blood
pressure in genetically hypertensive rats. Influence of the Y
chromosome. Hypertension. 1995;26:452459.
7.
Carswell HV,
Anderson NH, Clark JS, Graham D, Jeffs B, Dominiczak AF, Macrae IM.
Genetic and gender influences on sensitivity to focal cerebral
ischemia in the stroke-prone spontaneously hypertensive rat.
Hypertension. 1999;33:681685.
8.
Gratton JA, Sauter
A, Rudin M, Lees KR, McColl J, Reid JL, Dominiczak AF, Macrae IM.
Susceptibility to cerebral infarction in the stroke-prone spontaneously
hypertensive rat is inherited as a dominant trait.
Stroke. 1998;29:690694.
9.
Jeffs B, Negrin CD,
Graham D, Clark JS, Anderson N, Gauguier D, Dominiczak AF.
Applicability of a "speed" congenic strategy to dissect blood
pressure quantitative trait loci on rat chromosome 2.
Hypertension. 2000;35:179187.
10.
Clark JS, Jeffs B,
Davidson AO, Lee WK, Anderson NH, Bihoreau MT, Brosnan MJ, Devlin AM,
Kelman AW, Lindpaintner K, Dominiczak AF. Quantitative trait loci in
genetically hypertensive rats: possible sex specificity.
Hypertension. 1996;28:898906.
11.
Laird PW,
Zijderveld A, Linders K, Rudnicki MA, Jaenisch R, Berns A. Simplified
mammalian DNA isolation procedure. Nucleic
Acids Res. 1991;19:4293.
12. Tamura A, Graham DI, McCulloch J, Teasdale GM. Focal cerebral ischaemia in the rat, 1: description of technique and early neuropathological consequences following middle cerebral artery occlusion. J Cereb Blood Flow Metab. 1981;1:5360.[Medline] [Order article via Infotrieve]
13.
Osborne KA,
Shigeno T, Balarsky AM, Ford I, McCulloch J, Teasdale GM, Graham DI.
Quantitative assessment of early brain damage in a rat model of focal
cerebral ischaemia. J Neurol
Neurosurg Psychiatry. 1987;50:402410.
14.
Anderson NH,
Devlin AM, Graham D, Morton JJ, Hamilton CA, Reid JL, Schork NJ,
Dominiczak AF. Telemetry for cardiovascular monitoring
in a pharmacological study: new approaches to data analysis.
Hypertension. 1999;33:248255.
15.
Jones TJ, Dunphy
G, Milsted A, Ely D. Testosterone effects on renal
norepinephrine content and release in rats with different Y
chromosomes. Hypertension. 1998;32:880885.
16.
Rapp JP. Genetic
analysis of inherited hypertension in the rat.
Physiol Rev. 2000;80:135172.
17.
Calhoun DA,
Zhu S, Wyss M, Oparil S. Diurnal blood pressure variation and dietary
salt in spontaneously hypertensive rats.
Hypertension. 1994;24:17.
18. Jacob HJ, Lindpaintner K, Lincoln SE, Kusumi K, Bunker RK, Mao YP, Ganten D, Dzau VJ, Lander ES. Genetic mapping of a gene causing hypertension in the stroke-prone spontaneously hypertensive rat. Cell. 1991;67:213224.[Medline] [Order article via Infotrieve]
19. Hilbert P, Lindpaintner K, Beckmann JS, Serikawa T, Soubrier F, Dubay C, Cartwright P, De Gouyon B, Julier C, Takahasi S. Chromosomal mapping of two genetic loci associated with blood-pressure regulation in hereditary hypertensive rats. Nature. 1991;353:521529.[Medline] [Order article via Infotrieve]
20.
Ely D, Caplea A,
Dunphy G, Daneshvar H, Turner M, Milsted A, Takiyyudin M. Spontaneously
hypertensive rat Y chromosome increases indexes of sympathetic nervous
system activity. Hypertension. 1997;29:613618.
21. Ely DL, Falvo J, Dunphy G, Caplea A, Salisbury R, Turner M. The spontaneously hypertensive rat Y chromosome produces an early testosterone rise in normotensive rats. J Hypertens. 1994;12:769774.[Medline] [Order article via Infotrieve]
This article has been cited by other articles:
![]() |
D. Graham, N. N. Huynh, C. A. Hamilton, E. Beattie, R. A.J. Smith, H. M. Cocheme, M. P. Murphy, and A. F. Dominiczak Mitochondria-Targeted Antioxidant MitoQ10 Improves Endothelial Function and Attenuates Cardiac Hypertrophy Hypertension, August 1, 2009; 54(2): 322 - 328. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Graham, M. W. McBride, M. Gaasenbeek, K. Gilday, E. Beattie, W. H. Miller, J. D. McClure, J. M. Polke, A. Montezano, R. M. Touyz, et al. Candidate Genes That Determine Response to Salt in the Stroke-Prone Spontaneously Hypertensive Rat: Congenic Analysis Hypertension, December 1, 2007; 50(6): 1134 - 1141. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. R. Prows, A. P. Hafertepen, W. J. Gibbons Jr., A. V. Winterberg, and T. G. Nick A genetic mouse model to investigate hyperoxic acute lung injury survival Physiol Genomics, August 20, 2007; 30(3): 262 - 270. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. W. McBride, F. J. Charchar, D. Graham, W. H. Miller, P. Strahorn, F. J. Carr, and A. F. Dominiczak Functional genomics in rodent models of hypertension J. Physiol., January 1, 2004; 554(1): 56 - 63. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. J. Charchar, M. Tomaszewski, S. Padmanabhan, B. Lacka, M. N. Upton, G. C. Inglis, N. H. Anderson, A. McConnachie, E. Zukowska-Szczechowska, W. Grzeszczak, et al. The Y Chromosome Effect on Blood Pressure in Two European Populations Hypertension, February 1, 2002; 39(2): 353 - 356. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2001 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |